Medpace Holdings, Inc. (MEDP) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

Medpace Holdings, Inc. (MEDP) closed at USD 616.63 on 2026-10-14, a change of +6.2 % over the past year, with a market capitalization of USD 17.55B.

Medpace Holdings, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Medpace Holdings, Inc. key figures

Previous close

USD 616.63 (2026-10-14)

1-year change

+6.2 %

Market cap

USD 17.55B

Enterprise value

USD 17.19B

P/E ratio (trailing)

35.80

P/E ratio (forward)

32.54

EPS (trailing)

17.56

EPS (forward)

19.32

PEG ratio

2.93

Price to book

40.44

Revenue growth

17.2 %

Earnings growth

37.1 %

Dividend per share (trailing)

0.00

Short ratio

6.58

Employees

6,500

Analyst consensus (third-party)

hold

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Medpace Holdings, Inc. and compare it with other stocks.